ストックスクリーナーアプリを入手
60.72
0.62%
-0.38
アフターアワーズ：
60.72
前日終値:
$61.10
開ける：
$60.29
24時間の取引高:
443.79K
Relative Volume:
1.21
時価総額：
$2.11B
収益：
-
当期純損益:
$-91.00M
株価収益率:
-16.54
EPS:
-3.67
ネットキャッシュフロー:
$-74.38M
1週間 パフォーマンス:
+6.40%
1か月 パフォーマンス:
+5.16%
6か月 パフォーマンス:
+12.24%
1年 パフォーマンス:
+34.01%
1日の値動き範囲:
$60.19
$61.17
1週間の範囲:
$56.54
$61.63
52週間の値動き範囲:
$30.82
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
名前
Disc Medicine Inc
セクター
電話
(617) 674-9274
住所
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
60.72 | 2.12B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-06-11 | 再開されました | Raymond James | Strong Buy |
| 2025-02-27 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 開始されました | Jefferies | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-08-22 | 開始されました | Wells Fargo | Overweight |
| 2024-04-01 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 開始されました | H.C. Wainwright | Buy |
| 2023-05-17 | 開始されました | Raymond James | Outperform |
| 2023-04-28 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 開始されました | Stifel | Buy |
| 2023-04-20 | 開始されました | Morgan Stanley | Overweight |
| 2023-03-23 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-28 | 開始されました | SVB Securities | Outperform |
すべてを表示
Disc Medicine Inc (IRON) 最新ニュース
Disc Medicine’s (IRON) Rising Net Losses Could Be a Game Changer for Its Financial Strategy - simplywall.st
Disc Medicine Reports Q2 2025 Financial Results and Clinical Progress - TipRanks
Disc Medicine (IRON) Q2 Loss Widens 109% - AOL.com
Disc Medicine: Strong Financial Position and Promising Drug Pipeline Justify Buy Rating - TipRanks
Disc Medicine Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Disc Medicine Misses On Losses But Keeps Wall Street Optimistic - Finimize
Disc Medicine Stumbles On Earnings But Analysts Stay Bullish - Finimize
Disc Medicine (IRON) Q2 Loss Widens 109% - The Motley Fool
Disc Medicine Shares Fall After Wider-Than-Expected Q2 Loss - MarketScreener
Disc Medicine reports Q2 EPS ($1.58), consensus ($1.14) - TipRanks
Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Disc Medicine, Inc. SEC 10-Q Report - TradingView
How strong is Disc Medicine Inc. company’s balance sheetInvest confidently with real-time market updates - Jammu Links News
Is Disc Medicine Inc. a good long term investmentDiscover dynamic stocks ready to soar - Jammu Links News
Is it the right time to buy Disc Medicine Inc. stockMarket-leading growth rates - Jammu Links News
What catalysts could drive Disc Medicine Inc. stock higher in 2025Achieve consistent double-digit growth - Jammu Links News
What analysts say about Disc Medicine Inc. stockMaximize portfolio growth with professional advice - Jammu Links News
Is Disc Medicine Inc. a growth stock or a value stockMarket-beating performance - Jammu Links News
Published on: 2025-08-03 11:24:58 - Jammu Links News
What are analysts’ price targets for Disc Medicine Inc. in the next 12 monthsBuild a winning investment strategy today - Jammu Links News
How many analysts rate Disc Medicine Inc. as a “Buy”Realize exceptional returns through smart trading - Jammu Links News
How does Disc Medicine Inc. generate profit in a changing economyHigh-octane investment opportunities await - Jammu Links News
Insider Selling at Disc Medicine Inc.: A Signal or a Symptom? - AInvest
Is Disc Medicine Inc. stock overvalued or undervaluedLow Risk Report For Consistent Profits - Jammu Links News
Institutional Investors in Disc Medicine, Inc. (NASDAQ:IRON) See US$140m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them. - 富途牛牛
Why Disc Medicine Inc. stock attracts strong analyst attentionNews Based Entry Opportunity Alerts Detected - metal.it
Morgan Stanley Assumes Coverage of Disc Medicine (IRON) With $85 PT - MSN
How does Disc Medicine Inc. compare to its industry peersExpert Picks Watchlist For 2025 - Jammu Links News
Disc Medicine's NDA Submission for Bitopertin in EPP: A High-Probability Catalyst for Value Creation - AInvest
Disc Medicine, Inc. (IRON) Set to Submit NDA for Bitopertin in October 2025 - Insider Monkey
What is the dividend policy of Disc Medicine Inc. stockMaximize gains with strategic stock entries - Jammu Links News
Are Investors Undervaluing Disc Medicine, Inc. (NASDAQ:IRON) By 49%? - Yahoo Finance
How volatile is Disc Medicine Inc. stock compared to the marketBreakneck growth rates - jammulinksnews.com
Published on: 2025-07-28 05:56:42 - Jammu Links News
Should I hold or sell Disc Medicine Inc. stock in 2025Invest smarter with real-time trading signals - Jammu Links News
When is the best time to buy Disc Medicine Inc. stockWatchlist Winner Update - metal.it
Is Disc Medicine Inc. stock a growth or value play2x Return Forecast - metal.it
Insider Selling at Disc Medicine Inc.: A Balancing Act Between Portfolio Strategy and Investor Sentiment - AInvest
Disc Medicine Inc (IRON) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
1.56%
大文字化:
|
ボリューム (24 時間):